Medlab mxc.asx gains tga approval to sell a drug through special access scheme.
Shares spike 30% in one day.
The regulatory bodies are ready and willing.
The landscape is changing.
Over the next few years the landscape become littered with approved for sale medical marijuana products.
Zelda will own, not resell but own drugs in this space - the money is coming.
Be patient freinds.
We are at the begining of a generation defining event.
- Forums
- ASX - By Stock
- ZLD
- Ann: Zelda Focuses Clinical Trial Activity
Ann: Zelda Focuses Clinical Trial Activity, page-8
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
70.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.943M |
Open | High | Low | Value | Volume |
70.0¢ | 70.0¢ | 70.0¢ | $6 | 9 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14636 | 70.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
75.0¢ | 4521 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14636 | 0.700 |
2 | 3025 | 0.660 |
2 | 10910 | 0.650 |
1 | 2000 | 0.640 |
1 | 1600 | 0.625 |
Price($) | Vol. | No. |
---|---|---|
0.750 | 4521 | 5 |
0.785 | 343 | 1 |
0.795 | 6192 | 1 |
0.800 | 102 | 2 |
0.900 | 5000 | 1 |
Last trade - 12.18pm 13/11/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online